CRISPR Therapeutics Faces Challenging Times
CRISPR shares have slid 59% over three years, reflecting deeper business challenges.
- Latest
- Trending
CRISPR shares have slid 59% over three years, reflecting deeper business challenges.
Explore the latest market trends and social media insights to inform your investment strategies.
Intel's stock surges following Apollo's $5B equity offer, signaling confidence in the chipmaker's recovery efforts.
Explore investment opportunities in MCOs amid election risks and potential regulatory impacts on US healthcare industry.
NVIDIA and G42 team up on AI for climate tech, focusing on advanced weather forecasting and sustainable development.
Franklin Templeton leverages Solana blockchain to mint tokens as authentic ownership records in a pioneering financial service move.
Explore expert-recommended investment strategies for a $1 million portfolio, focusing on diversification and risk management.
Intel shares rise 7.9% post-CEO update on cost-cutting, new contracts. Key support at $20, resistance at $25.
Perplexity plans a new AI-driven ad model to rival Google, aiming for premium brand engagement.
Hackers claim Dell's second data breach in a week, leaking sensitive data from Atlassian tools: Jira, Jenkins, and Confluence.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.